- Home
- GEMI vs ZLAB Comparison
GEMI vs ZLAB Comparison
Compare GEMI & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEMI
- ZLAB
- Stock Information
- Founded
- GEMI 2014
- ZLAB 2013
- Country
- GEMI United States
- ZLAB China
- Employees
- GEMI N/A
- ZLAB N/A
- Industry
- GEMI
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- GEMI
- ZLAB Health Care
- Exchange
- GEMI Nasdaq
- ZLAB Nasdaq
- Market Cap
- GEMI 2.9B
- ZLAB 3.2B
- IPO Year
- GEMI 2025
- ZLAB 2017
- Fundamental
- Price
- GEMI $12.17
- ZLAB $20.42
- Analyst Decision
- GEMI Buy
- ZLAB Buy
- Analyst Count
- GEMI 8
- ZLAB 6
- Target Price
- GEMI $28.13
- ZLAB $57.22
- AVG Volume (30 Days)
- GEMI 1.9M
- ZLAB 908.9K
- Earning Date
- GEMI 11-10-2025
- ZLAB 11-06-2025
- Dividend Yield
- GEMI N/A
- ZLAB N/A
- EPS Growth
- GEMI N/A
- ZLAB N/A
- EPS
- GEMI N/A
- ZLAB N/A
- Revenue
- GEMI $162,529,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- GEMI $23.71
- ZLAB $40.71
- Revenue Next Year
- GEMI $96.53
- ZLAB $50.42
- P/E Ratio
- GEMI N/A
- ZLAB N/A
- Revenue Growth
- GEMI 65.61
- ZLAB 24.14
- 52 Week Low
- GEMI $11.31
- ZLAB $20.25
- 52 Week High
- GEMI $45.89
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- GEMI N/A
- ZLAB 20.16
- Support Level
- GEMI N/A
- ZLAB $21.59
- Resistance Level
- GEMI N/A
- ZLAB $22.28
- Average True Range (ATR)
- GEMI 0.00
- ZLAB 0.85
- MACD
- GEMI 0.00
- ZLAB -0.17
- Stochastic Oscillator
- GEMI 0.00
- ZLAB 3.30
About GEMI Gemini Space Station Inc. Class A Common Stock
Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.